Chronic low-grade inflammation has been proposed to contribute to development of cardiovascular disease and atherosclerosis [11] and several inflammatory markers have been shown to be reduced by treatment with GLP-1 RA [12]. Here, GLP1R is linked to cardiovascular disorder.